Publications by authors named "Adriaan A Voors"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

63,585

Total Likes

3,380

Extended Reach

5,847,227

Social Features

776
F
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Muthiah Vaduganathan, Brian Claggett, Pardeep S Jhund, Akshay S Desai, Alasdair D Henderson, Carolyn S P Lam, Bertram Pitt, Michele Senni

N Engl J Med· October 2024

Videos about Article: user user user 14

17 1 5 230 9 81

View All Article and Social Media Activity
B
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
Scott D Solomon, John W Ostrominski, Muthiah Vaduganathan, Brian Claggett, Pardeep S Jhund, Akshay S Desai, Carolyn S P Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah

June 2024

Videos about Article: user user

2 104

View All Article and Social Media Activity
T
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Adriaan A Voors, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Jasper Tromp

Nat Med· March 2022

Videos about Article: user user user

3 1 6 211 4 18

View All Article and Social Media Activity
V
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia

May 2020

Videos about Article: user user user 1

4 5 203 4 26

View All Article and Social Media Activity
I
Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
John W Ostrominski, Henri Lu, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Adriaan A Voors

Diabetes Care· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study.
Bart J van Essen, Nathalie Ang En Dan, Ganash N Tharsana, Palvinder Kaur, J E Emmens, Adriaan A Voors

Int J Cardiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD.
Mark André de la Rambelje, Adriaan A Voors, Peter J Greasley, Mario Berger, Hiddo J L Heerspink

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Adults With Transposition of the Great Arteries With a Systemic Right or Left Ventricle.
Mohammad Mostafa Ansari Ramandi, Liesbet Van Bulck, Daan C H Ceelen, Adriaan A Voors, Eva Goossens

Can J Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF Trial.
Finnian R Mc Causland, Safia Chatur, Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac, Adriaan A Voors

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
Alberto Foà, Muthiah Vaduganathan, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Adriaan A Voors

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy", Journal of Cardiac Failure volume 31 (2025) P1578-1581/ PMID: 40414278.
Iris E Beldhuis, Jozine M Ter Maaten, Peter van der Meer, Jenifer E Coster, Lukas Baumhove, Adriaan A Voors

J Card Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Pharmacological and Non-Pharmacological Decongestion Strategies in Acute Heart Failure - Evidence and Practical Guidance.
Lara E E C Zonneveld, Kevin Damman, Maria Rosa Costanzo, Adriaan A Voors, G Michael Felker

J Card Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary lipid burden indices predict non-culprit major adverse cardiac events independently of novel LDL estimates: Insights from the LRP study.
Kayode O Kuku, Hector M Garcia-Garcia, Gary S Mintz, Priti Shah, Stephen Sum, Adriaan A Voors

Atherosclerosis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in Transcatheter Aortic Valve Implantation Outcomes in Patients on Oral Anticoagulants: A Popular PAUSE TAVI SubAnalysis.
Kees H van Bergeijk, Daniël C Overduin, Constantijn S Venema, Dirk Jan van Ginkel, Hindrik W van der Werf, Adriaan A Voors

J Am Heart Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone in patients with severe heart failure: The FINEARTS-HF trial.
Riccardo M Inciardi, Henri Lu, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Adriaan A Voors

Eur J Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure.
Daan C H Ceelen, Jozine M Ter Maaten, Geert H D Voordes, Gad Cotter, Beth A Davison, Adriaan A Voors

Eur J Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
John W Ostrominski, Brendon L Neuen, Brian L Claggett, Gerasimos Filippatos, Akshay S Desai, Adriaan A Voors

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HF.
João Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, Ian Kulac, John W Ostrominski, Adriaan A Voors

Eur J Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction.
Sher May Ng, Geert H D Voordes, Michelle Lobeek, Michiel Rienstra, Adriaan A Voors

Int J Cardiol Heart Vasc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy.
Palak Shah, Yinggan Zheng, Burkert Pieske, Vojtech Melenovsky, Carolyn S P Lam, Adriaan A Voors

Circ Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone and Quality of Life Assessed Using the EuroQol 5-Dimension Questionnaire Level-Sum-Score in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction.
Mingming Yang, Misato Chimura, Carolyn S P Lam, Michele Senni, Adriaan A Voors

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient loop diuretic use and the effect of natriuresis-guided diuretic therapy: A prespecified sub-analysis of the PUSH-AHF study.
Lara E E C Zonneveld, Iris E Beldhuis, Hailun Qin, Dirk J van Veldhuisen, Jenifer E Coster, Adriaan A Voors

Eur J Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial.
John W Ostrominski, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Carolyn S P Lam, Adriaan A Voors

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
Mohammad A Almesned, Bart J van Essen, Adriaan A Voors, Erik Lipsic

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein profiles and associated biological pathways among different etiologies of chronic kidney disease: new insights from DAPA-CKD.
Mark André de la Rambelje, Iris E Beldhuis, Hiddo J L Heerspink, Peter J Greasley, Rasmus Agren, Adriaan A Voors

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Finerenone on Morbidity and Mortality in CKD.
John W Ostrominski, Gerasimos Filippatos, Brian L Claggett, Zi Michael Miao, Akshay S Desai, Adriaan A Voors

J Am Soc Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying congestion phenotypes using unsupervised machine learning in acute heart failure.
Tripti Rastogi, Olivier Hutin, Jozine M Ter Maaten, Guillaume Baudry, Luca Monzo, Adriaan A Voors

Eur Heart J Digit Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framingham risk score associates with incident cancer and heart failure.
Pieter F van den Berg, Laura I Yousif, Yvonne Koop, Ezgi Hatip Ünlü, Melis Asik, Adriaan A Voors

Eur J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Robert J Mentz, Javed Butler, Ciaran J McMullan, Daniel M Wojdyla, Kevin J Anstrom, Adriaan A Voors

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis